Document Details
Form
Filing Date
Feb 11, 2022
Document Date
Feb 9, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.
Filer
PARTRIDGE ANDREW JOHN
Turning Point Therapeutics is now a
Bristol Myers Squibb company
Select OK for information about Turning Point Therapeutics.
Select BMS to learn more about Bristol Myers Squibb